Science & Humans Appoints Karim "Matt" Nassar as Chief Growth Officer

MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, has announced the appointment of Karim (Matt) Nassar as Chief Growth Officer. Nassar joins S&H at a crucial time as the company aims to extend its direct-to-consumer hormone health program to private payers, brokers, and plan sponsors such as employers and unions.

Nassar's past achievements include his role as CEO of Mednow, a digital pharmacy he co-founded. During his tenure, Mednow's market cap reached $145M, and the company expanded to six provinces, serving over 20 million Canadians. Under his leadership, Mednow generated $30 million in operating revenue and an additional $10 million in organic growth over three years.

Nassar's decision to join S&H aligns with his belief that the company has the necessary market share and intellectual property to lead in the healthy aging and longevity sector. His expertise is expected to enhance S&H's offerings and improve customer retention and adoption.

S&H Founder and CEO, Aftab Pashaw, expressed enthusiasm for Nassar's appointment, citing his expertise in scaling brands and driving innovation as pivotal to the company's future success.